The proteasome of malaria parasites: A multi-stage drug target for chemotherapeutic intervention?
about
26S proteasome regulatory subunit RPN1, putative26S proteasome regulatory subunit RPN12, putativeproteasome subunit alpha type-3, putativeproteasome subunit beta type-1, putativeproteasome subunit alpha type-2, putativeproteasome subunit alpha type-5, putativeproteasome subunit alpha type-6, putative26S proteasome regulatory subunit RPN8, putativeproteasome subunit beta type-6, putative26S proteasome regulatory subunit p55, putativeubiquitin domain-containing protein DSK2, putative26S protease regulatory subunit 10B, putative26S protease regulatory subunit 7, putativeproteasome subunit beta type-7, putative26S proteasome regulatory subunit RPN3, putativeproteasome subunit alpha type-4, putativeproteasome subunit alpha type-7, putative26S proteasome regulatory subunit RPN11, putative26S proteasome regulatory subunit RPN2, putativeproteasome subunit beta type-2, putativeproteasome subunit alpha type-1, putative26S proteasome regulatory subunit RPN1, putative26S proteasome regulatory subunit RPN12, putativeproteasome subunit alpha type-3, putativeproteasome subunit beta type-1, putativeproteasome subunit alpha type-2, putativeproteasome subunit alpha type-5, putativeproteasome subunit alpha type-6, putative26S proteasome regulatory subunit RPN8, putativeproteasome subunit beta type-6, putative26S proteasome regulatory subunit p55, putativeubiquitin domain-containing protein DSK2, putative26S protease regulatory subunit 10B, putative26S protease regulatory subunit 7, putativeproteasome subunit beta type-7, putative26S proteasome regulatory subunit RPN3, putativeproteasome subunit alpha type-4, putativeproteasome subunit alpha type-7, putative26S proteasome regulatory subunit RPN11, putative26S proteasome regulatory subunit RPN2, putative
P1343
Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmissionCharacterization of the autophagy marker protein Atg8 reveals atypical features of autophagy in Plasmodium falciparumHigh resolution microscopy reveals an unusual architecture of the Plasmodium berghei endoplasmic reticulumBlocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodesTargeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistanceCharacterization of the 26S proteasome network in Plasmodium falciparumLys48 ubiquitination during the intraerythrocytic cycle of the rodent malaria parasite, Plasmodium chabaudiAssessing subunit dependency of the Plasmodium proteasome using small molecule inhibitors and active site probesIdentification of potent and selective non-covalent inhibitors of the Plasmodium falciparum proteasome.Changes in the transcriptome of the malaria parasite Plasmodium falciparum during the initial phase of transmission from the human to the mosquito.In vitro antimalarial activity of novel semisynthetic nocathiacin I antibioticsStructure- and function-based design of Plasmodium-selective proteasome inhibitorsTreatment of Plasmodium chabaudi Parasites with Curcumin in Combination with Antimalarial Drugs: Drug Interactions and Implications on the Ubiquitin/Proteasome System.Broad-spectrum antimalarial activity of peptido sulfonyl fluorides, a new class of proteasome inhibitors.WIPO Re:Search: a consortium catalyzing research and product development for neglected tropical diseases.Transcriptional Profiling Defines Histone Acetylation as a Regulator of Gene Expression during Human-to-Mosquito Transmission of the Malaria Parasite Plasmodium falciparum.The proteasome of the differently-diverged eukaryote Giardia lamblia and its role in remodeling of the microtubule-based cytoskeleton.Targeting proteasomes in infectious organisms to combat disease.Protein Degradation Systems as Antimalarial Therapeutic Targets.Development of two novel high-throughput assays to quantify ubiquitylated proteins in cell lysates: application to screening of new anti-malarials.The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug TargetMetallopeptidases of Toxoplasma gondii: in silico identification and gene expression.
P2860
Q56558263-1355285D-DC33-48B4-9F10-6108A267DEF6Q56559172-9FEF2B74-3F43-4B0A-AB2C-468B8E2CC269Q56559290-C01A62A6-C5CA-408B-8D38-CC034C817216Q56561042-2B6933E0-4CFB-44EF-AB79-534EBF43A5B7Q56561866-B857D969-E465-4601-90CD-C27EA08E3412Q56564003-412743CC-7F1F-4D80-9810-78F22404ADD4Q56564474-6D5B4F91-E33C-40E9-9E5B-A72D43602FF6Q56568804-A50BE412-27B4-4D31-A7D8-C4B4C03B7C75Q56569755-2B6B4287-A597-4228-BAAE-689F6A6A2706Q56571013-78B99B0C-4D65-4C4A-A773-145EC554DC86Q56574110-596DE580-F149-4697-A6C7-4C3999A73A2EQ56583464-92DF7269-B792-4F79-AE1B-6B6CE3DAA489Q56584547-F5C2F49C-58EC-4968-949B-F9CE6E25D02CQ56587081-8ACFBCC5-D616-442A-8D74-47BB9FEAF4FDQ56588271-59FF9ACC-000B-49E8-AE6A-BE8D629B1ABDQ56589672-192684C6-510A-4407-B3E5-667CBFE534B8Q56589684-E0B2F3F2-9950-4F69-81BE-B8EBA84DF946Q56590814-A6668184-B319-45C8-967F-A4A39AFF68C5Q56597277-EA5A5142-F7EC-406F-8F86-8BE0E74BD213Q56597421-4CA251BA-F35A-4821-9156-C0E07E7205E5Q56597551-EC11A4D0-5D9A-4066-8F7A-6C42E7F6E664Q56708922-ED0E1ACF-96A6-4E27-BA04-2A401244C362Q56709844-40A7B115-EE5A-41B6-B5E5-47B70F2A824CQ56710070-5C0FE879-3F23-4E8B-979C-C9214D0C327EQ56713060-688B963E-1964-48DF-934A-1E37B0178FAEQ56715537-222C3CA5-F419-4276-BFEA-7135B491C2A0Q56721574-582211A0-4366-475E-9F2C-6D0431902AD1Q56722425-1E41004A-DA1D-4093-BBFC-715E31F8C054Q56724068-061F8507-D214-4C91-9A61-CAA79013C236Q56724954-5F2E2464-CAE5-43D8-9025-CAAB05B085B5Q56728937-7A979191-4466-47B0-9BA8-B3EA4F48DF04Q56732625-BD77C45B-D3D4-4749-AF48-08A97C27FE64Q56737055-CE066F14-4695-437B-AAF9-DE489105759CQ56737233-F25803A2-C21B-4A0A-9B75-BCDF20B5A498Q56737823-0FD4DE64-BD50-41FF-BB5D-8DDFBAD6ED9CQ56738578-9878A134-44E8-4C57-ABCA-28476553054BQ56739637-5813278F-B53A-4991-B48D-CE3F9E3C7F72Q56739640-C4B41152-48C9-444F-BAD9-17E503EFB540Q56740027-8905F5E9-D3FD-4B67-8E13-F35F34CEF0A0Q56744371-FE009B23-6E7C-4A35-8716-C308BDC18708
P1343
Q27972593-F2E45055-E542-4E5F-B1CF-BA3D422298A7Q27973707-13D8F348-6C98-4FE9-81A2-5FD81211A798Q27973738-E99376AC-9FB2-4DEA-93F9-A9E4A213A3BEQ28536452-7817C2C2-580F-4D94-9012-029C0EBC0753Q28542496-5B8F3E1D-05FA-4C8F-A1E7-2CCFA8C14E44Q28546636-DDC9F5AB-47DE-4691-8C12-CCF649E9A56EQ30043793-6C79F57D-1993-4FB8-8363-9BAD3C0B0586Q33788240-093BAB3C-EF98-4830-8C5C-16C78A933664Q34061291-D20F81ED-0DDD-4F24-A154-47BFFF74713DQ34282526-1F1AF793-0187-4D61-8415-75454F2AF1F6Q34668840-56C2220F-5D39-40EB-B62C-4B2BE6679900Q35607875-F68D0164-1354-4B53-9341-272B32C32CA6Q36584903-F843C50E-750B-4B78-A851-CEF9A2FC3FB7Q36830110-19729FAD-AEA6-47E5-A72F-73B892F0DA04Q37036656-339050D4-FE06-4CEB-B037-0B36C0314A8FQ38162993-B6173045-6B82-44BE-9B3B-B115B8FC4A71Q38632921-C9A73A17-1DB0-4F91-A24F-B8DD515968FAQ39052617-676B5888-A174-4938-B445-C5A08545A9FFQ39103077-1271710C-2324-416F-92A3-1FB739B78C69Q39422863-F8E7A1C3-6E17-4AFE-9E84-05E6D74B42EFQ40943451-795E3A84-F8D8-488F-A699-A4FF269A92FCQ41519882-4BB929C4-40F5-4F9A-83FE-E9A81682EE3BQ55283527-FFDFEAB5-6078-46C7-AE7E-EE0FF796A460
P2860
The proteasome of malaria parasites: A multi-stage drug target for chemotherapeutic intervention?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The proteasome of malaria para ...... chemotherapeutic intervention?
@en
type
label
The proteasome of malaria para ...... chemotherapeutic intervention?
@en
prefLabel
The proteasome of malaria para ...... chemotherapeutic intervention?
@en
P2860
P921
P1476
The proteasome of malaria para ...... chemotherapeutic intervention?
@en
P2093
Hans-Dieter Arndt
Makoah Nigel Aminake
P2860
P356
10.1016/J.IJPDDR.2011.12.001
P577
2012-01-09T00:00:00Z